Medica SpA
MIL:MDC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
Medica SpA
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IT |
M
|
Medica SpA
MIL:MDC
|
125.9m EUR |
6%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.5T JPY |
30%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.9B CHF |
14%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
127.1B DKK |
28%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.3B USD |
16%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
48B CNY |
38%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5B GBP |
15%
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.1B USD |
2%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.7B CHF |
28%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.5B USD |
11%
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
809.3B JPY |
18%
|
Medica SpA
Glance View
Medica SpA engages in the design, development, production, and sale of medical devices and electro-medical machines for blood filtration as well as water treatment. The company is headquartered in Medolla, Modena. The company went IPO on 2021-11-03. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. The company also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. The company is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The firm provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. The company operates globally.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Medica SpA's most recent financial statements, the company has Operating Margin of 5.9%.